Precigen (PGEN) Divestments (2018 - 2022)

Precigen (PGEN) posted quarterly Divestments of $936000.0 for Q4 2022, down 98.54% quarter-over-quarter from $64.2 million in Q1 2020.

Precigen (PGEN) Divestments (2018 - 2022) Analysis & Trends

Precigen (PGEN) has reported Divestments for 4 consecutive years, with $936000.0 the latest figure, recorded in Q4 2022.

In Q4 2022, Divestments changed N/A year-over-year to $936000.0; the TTM figure through Dec 2023 stood at $936000.0 (changed 0.0% YoY), while the FY2022 annual figure was $162.3 million, changed N/A from the prior year.
Divestments fell to $936000.0 in Q4 2022 per PGEN's latest filing, from $64.2 million in the prior quarter.
Across five years, Divestments topped out at $64.2 million in Q1 2020 and bottomed at -$125000.0 in Q4 2019.
Historically, Divestments has averaged $13.6 million across 4 years, with a median of $936000.0 in 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	9.82 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-13.21 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Precigen	2.18 Bn	2.18 Bn	52.17 Mn	-

Download Data